VTYX: ventyxbio.com Stock Quotes

Ventyx Biosciences (VTYX) is a clinical-stage immunology biotech whose current R&D expenditures result in a negative financial bottom line, although future royalties from molecule licensing will ensure high margins. This chart of stock quotes, which carry the value 14.02, accompanies the development of convenient oral treatments for autoimmune pathologies. Manufacturing processes rely on the capacities of external contract sites with strict quality control.

ventyxbio.com - VTYX Market Price (period 07/04/2022 - 03/14/2026)

Ventyx Bio - analytical breakdowns and key metrics (VTYX)

- current price and projected stock value:

Stock Quotes Ventyx Biosciences, Inc.|VTYX - Price Target Chart

- market capitalization information:

Market Valuation Ventyx Biosciences Inc.|VTYX - Aggregate Business Value

- issuer book value statistics:

Accounting Value per Share Ventyx Biosciences|VTYX - Total Stockholders' Equity|Market Cap to Net Assets Ratio ventyxbio.com|VTYX - Total Business Assets

- debt and solvency information:

- financial results and valuation multiples details:

VTYX - Net Income|Projected Future Earnings Ventyx Biosciences|VTYX - P/E Multiple|Projected Price to Earnings Ventyx Bio|VTYX - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Ventyx Biosciences, Inc.|VTYX - Operating income before deduction of amortization|Earnings per share for the last twelve months Ventyx Biosciences|VTYX - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months ventyxbio.com|VTYX - Net earnings per share growth this year|Expected earnings per share growth for next year Ventyx Biosciences

- sales and revenue data:

VTYX - Revenue and Sales Volume|Company Projected Revenue Ventyx Bio|VTYX - Market Cap to Revenue Ratio|Forward P/S Multiple Ventyx Biosciences Inc.|VTYX - Trailing Twelve Months Revenue Growth

Fundamental valuation:ventyxbio.com

Signature product of Ventyx Biosciences Inc.

Professional investors select resilient assets by analyzing the market equilibrium of a security's value through the lens of its reaction to external shocks. Trading dynamics on GURU.Markets visualize the amplitude of price fluctuations, which for Ventyx Biosciences (VTYX) reflects the balance between volatility risks and the fundamental value of a company developing sustainable synthesis of immunological drugs while adhering to strict ESG ethical standards.

Analysis of competing companies